{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    4
  ],
  "modelUsed": "gemini-3-flash-preview",
  "confidence": 1.0,
  "amendmentDetails": {
    "studyAmendmentImpacts": [
      {
        "id": "impact_1",
        "amendmentId": "amend_5",
        "affectedSection": "Section 9 - Statistical Considerations",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Revised secondary efficacy endpoint analysis to allow formal statistical testing and updated multiplicity adjustments."
      },
      {
        "id": "impact_2",
        "amendmentId": "amend_5",
        "affectedSection": "Section 1.3 - Schedule of Activities",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Added exit interviews and clarified electronic patient diary (ePD) training and device distribution."
      },
      {
        "id": "impact_3",
        "amendmentId": "amend_5",
        "affectedSection": "Cover page and Section 2",
        "impactLevel": "Administrative",
        "instanceType": "StudyAmendmentImpact",
        "description": "Introduction of the International Nonproprietary Name (INN) efanesoctocog alfa."
      }
    ],
    "studyAmendmentReasons": [
      {
        "id": "reason_1",
        "amendmentId": "amend_5",
        "reasonText": "To include analysis of Patient Reported Outcomes within the overall statistical testing",
        "category": "Scientific",
        "isPrimary": true,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_2",
        "amendmentId": "amend_5",
        "reasonText": "To evaluate participantsâ€™ expectations of treatment and perception of treatment impact",
        "category": "Scientific",
        "isPrimary": true,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_3",
        "amendmentId": "amend_5",
        "reasonText": "Update to align with the statistical analytical plan (SAP)",
        "category": "Regulatory",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_4",
        "amendmentId": "amend_5",
        "reasonText": "To give greater flexibility to participants who undergo minor dental surgery outside of the hospital",
        "category": "Operational",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      }
    ],
    "studyChanges": [
      {
        "id": "change_1",
        "amendmentId": "amend_5",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "Cover page",
        "beforeText": "BIVV001",
        "afterText": "BIVV001 (efanesoctocog alfa)",
        "summary": "The international nonproprietary name (INN), efanesoctocog alfa, was added."
      },
      {
        "id": "change_2",
        "amendmentId": "amend_5",
        "changeType": "Modification",
        "instanceType": "StudyChange",
        "sectionNumber": "9.1",
        "beforeText": "null",
        "afterText": "Participants in Arm A must have at least 6 months of study duration in both this study and in observational study 242HA201/OBS16221.",
        "summary": "Updated selection criteria for participants included in the intra-patient comparison of ABR."
      },
      {
        "id": "change_3",
        "amendmentId": "amend_5",
        "changeType": "Clarification",
        "instanceType": "StudyChange",
        "sectionNumber": "8.1.2",
        "beforeText": "Treatment Satisfaction Questionnaire for Medication",
        "afterText": "9-item version of the Treatment Satisfaction Questionnaire for Medication (TSQM-9)",
        "summary": "Clarified the specific version of the TSQM being used and updated the appendix."
      },
      {
        "id": "change_4",
        "amendmentId": "amend_5",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "8.1.3",
        "beforeText": "null",
        "afterText": "Exit interview and footnote kk",
        "summary": "Added exit interview assessment, related endpoint, and description section."
      },
      {
        "id": "change_5",
        "amendmentId": "amend_5",
        "changeType": "Modification",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "beforeText": "null",
        "afterText": "In the case of minor dental surgery, blood samples can be drawn within 3 days prior to the day of surgery.",
        "summary": "Added flexibility for blood draw timing for minor dental surgery."
      }
    ],
    "summary": {
      "impactCount": 3,
      "reasonCount": 4,
      "changeCount": 5
    }
  }
}